Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04163432
Title Staggered, Chemo-Immunotherapy With Durvalumab, MEDI4736 Pemetrexed & Carboplatin (PC) for Metastatic Non-Squamous NSCLC (STAGGER)
Acronym STAGGER
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Utah
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST